Bacteria as Nanoparticle Carriers for Immunotherapy in Oncology

The use of nanocarriers to deliver antitumor agents to solid tumors must overcome biological barriers in order to provide effective clinical responses. Once within the tumor, a nanocarrier should navigate into a dense extracellular matrix, overcoming intratumoral pressure to push it out of the disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreno, Víctor M., Baeza, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027800/
https://www.ncbi.nlm.nih.gov/pubmed/35456618
http://dx.doi.org/10.3390/pharmaceutics14040784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027800/
https://www.ncbi.nlm.nih.gov/pubmed/35456618
http://dx.doi.org/10.3390/pharmaceutics14040784

Ejemplares similares